S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer

American Journal of Pathology

Volumn 177, Issue 2, 2010, Pages 586-597

  Wang, Xiao Hong ^a   Zhang, Lian Hai ^a   Zhong, Xi Yao ^a   Xing, Xiao Fang ^a   Liu, Yi Qiang ^a   Niu, Zhao Jian ^b   Peng, Yong ^a   Du, Hong ^a   Zhang, Gui Guo ^a   Hu, Ying ^a   Liu, Ni ^a   Zhu, Yu Bing ^a   Ge, Shao Hua ^a   Zhao, Wei ^a   Lu, Ai Ping ^a   Li, Ji You ^a   Ji, Jia Fu ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3;

ACETYLATION; ADULT; AGED; ARTICLE; CANCER CELL; CONTROLLED STUDY; DNA METHYLATION; EPIGENETICS; EXON; FEMALE; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; STOMACH CANCER;

EID: 77957279576     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091217     Document Type: Article

References (51)

1. Ferrari S, Calabretta B, deRiel JK, Battini R, Ghezzo F, Lauret E, Griffin C, Emanuel BS, Gurrieri F, Baserga R: Structural and functional analysis of a growth-regulated gene, the human calcyclin. J Biol Chem 1987, 262:8325-8332
2. Donato R: S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 2001, 33:637-668
3. Calabretta B, Battini R, Kaczmarek L, de Riel JK, Baserga R: Molecular cloning of the cDNA for a growth factor-inducible gene with strong homology to S-100, a calcium-binding protein. J Biol Chem 1986, 261:12628-12632 (Pubitemid 17204217)
4. Calabretta B, Kaczmarek L, Mars W, Ochoa D, Gibson CW, Hirschhorn RR, Baserga R: Cell-cycle-specific genes differentially expressed in human leukemias. Proc Natl Acad Sci USA 1985, 82:4463-4467 (Pubitemid 15234254)
5. Cross SS, Hamdy FC, Deloulme JC, Rehman I: Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: s100A6. S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005, 46:256-269
6. Emberley ED, Murphy LC, Watson PH: S100 proteins and their influence on pro-survival pathways in cancer. Biochem Cell Biol 2004, 82:508-515
7. Golitsina NL, Kordowska J, Wang CL, Lehrer SS: Ca2+-dependent binding of calcyclin to muscle tropomyosin. Biochem Biophys Res Commun 1996, 220:360-365 (Pubitemid 126351722)
8. Mani RS, McCubbin WD, Kay CM: Calcium-dependent regulation of caldesmon by an 11-kDa smooth muscle calcium-binding protein, caltropin. Biochemistry 1992, 31:11896-11901
9. Slomnicki LP, Nawrot B, Lesniak W: S100A6 binds p53 and affects its activity. Int J Biochem Cell Biol 2009, 41:784-790
10. Tsoporis JN, Izhar S, Parker TG: Expression of S100A6 in cardiac myocytes limits apoptosis induced by tumor necrosis factor-alpha. J Biol Chem 2008, 283:30174-30183
11. Filipek A, Kuznicki J: Calcyclin-from basic research to clinical implications. Acta Biochim Pol 1993, 40:321-327
12. Shekouh AR, Thompson CC, Prime W, Campbell F, Hamlett J, Herrington CS, Lemoine NR, Crnogorac-Jurcevic T, Buechler MW, Friess H, Neoptolemos JP, Pennington SR, Costello E: Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics 2003, 3:1988-2001 (Pubitemid 37305893)
13. Brown LM, Helmke SM, Hunsucker SW, Netea-Maier RT, Chiang SA, Heinz DE, Shroyer KR, Duncan MW, Haugen BR: Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue. Mol Carcinog 2006, 45:613-626
14. Stulik J, Osterreicher J, Koupilova K, Knizek J, Bures J, Jandik P, Langr F, Dedic K, Schafer BW, Heizmann CW: Differential expression of the Ca2+ binding S100A6 protein in normal, preneoplastic and neoplastic colon mucosa. Eur J Cancer 2000, 36:1050-1059 (Pubitemid 30316432)
15. Komatsu K, Kobune-Fujiwara Y, Andoh A, Ishiguro S, Hunai H, Suzuki N, Kameyama M, Murata K, Miyoshi J, Akedo H, Tatsuta M, Nakamura H: Increased expression of S100A6 at the invading fronts of the primary lesion and liver metastasis in patients with colorectal adenocarcinoma. Br J Cancer 2000, 83:769-774
16. Weterman MA, Stoopen GM, van Muijen GN, Kuznicki J, Ruiter DJ, Bloemers HP: Expression of calcyclin in human melanoma cell lines correlates with metastatic behavior in nude mice. Cancer Res 1992, 52:1291-1296
17. Pedrocchi M, Schafer BW, Mueller H, Eppenberger U, Heizmann CW: Expression of Ca(2+)-binding proteins of the S100 family in malignant human breast-cancer cell lines and biopsy samples. Int J Cancer 1994, 57:684-690
18. Rehman I, Cross SS, Catto JW, Leiblich A, Mukherjee A, Azzouzi AR, Leung HY, Hamdy FC: Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer. Prostate 2005, 65:322-330 (Pubitemid 41759964)
19. Rehman I, Cross SS, Azzouzi AR, Catto JW, Deloulme JC, Larre S, Champigneuille J, Fromont G, Cussenot O, Hamdy FC: S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Br J Cancer 2004, 91:739-744 (Pubitemid 39141634)
20. Kim J, Kim J, Yoon S, Joo J, Lee Y, Lee K, Chung J, Choe I: S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma. Hepatol Res 2002, 23:274-286 (Pubitemid 41116588)
21. De Petris L, Orre LM, Kanter L, Pernemalm M, Koyi H, Lewensohn R, Lehtio J: Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. Lung Cancer 2009, 63:410-417
22. Yang YQ, Zhang LJ, Dong H, Jiang CL, Zhu ZG, Wu JX, Wu YL, Han JS, Xiao HS, Gao HJ, Zhang QH: Upregulated expression of S100A6 in human gastric cancer. J Dig Dis 2007, 8:186-193
23. Lesniak W, Slomnicki LP, Kuznicki J: Epigenetic control of the S100A6 (calcyclin) gene expression. J Invest Dermatol 2007, 127:2307-2314 (Pubitemid 47619754)
24. Lesniak W, Swart GW, Bloemers HP, Kuznicki J: Regulation of cell specific expression of calcyclin (S100A6) in nerve cells and other tissues. Acta Neurobiol Exp (Wars) 2000, 60:569-575
25. American Joint Committee on Cancer: Gastric Cancer. AJCC Cancer Staging. Manual, 2002, 6th ed., New York: Springer-Verlag, pp. 99-103
26. Ji J, Chen X, Leung SY, Chi JT, Chu KM, Yuen ST, Li R, Chan AS, Li J, Dunphy N, So S: Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. Oncogene 2002, 21:6549-6556 (Pubitemid 35155459)
27. Packeisen J, Buerger H, Krech R, Boecker W: Tissue microarrays: a new approach for quality control in immunohistochemistry. J Clin Pathol 2002, 55:613-615
28. Vimalachandran D, Greenhalf W, Thompson C, Luttges J, Prime W, Campbell F, Dodson A, Watson R, Crnogorac-Jurcevic T, Lemoine N, Neoptolemos J, Costello E: High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients. Cancer Res 2005, 65:3218-3225 (Pubitemid 40524604)
29. Ohuchida K, Mizumoto K, Ishikawa N, Fujii K, Konomi H, Nagai E, Yamaguchi K, Tsuneyoshi M, Tanaka M: The role of S100A6 in pancreatic cancer development and its clinical implication as a diagnostic marker and therapeutic target. Clin Cancer Res 2005, 11:7785-7793 (Pubitemid 41611622)
30. Kill IR: Localisation of the Ki-67 antigen within the nucleolus. Evidence for a fibrillarin-deficient region of the dense fibrillar component. J Cell Sci 1996, 109 (Pt 6):1253-1263 (Pubitemid 26190477)
31. Gardiner-Garden M, Frommer M: CpG islands in vertebrate genomes. J Mol Biol 1987, 196:261-282
32. Maelandsmo GM, Florenes VA, Mellingsaeter T, Hovig E, Kerbel RS, Fodstad O: Differential expression patterns of S100A2. S100A4 and S100A6 during progression of human malignant melanoma. Int J Cancer 1997, 74:464-469 (Pubitemid 27400171)
33. Breen EC, Tang K: Calcyclin (S100A6) regulates pulmonary fibroblast proliferation, morphology, and cytoskeletal organization in vitro. J Cell Biochem 2003, 88:848-854
34. Spiechowicz M, Zylicz A, Bieganowski P, Kuznicki J, Filipek A: Hsp70 is a new target of Sgt1-an interaction modulated by S100A6. Biochem Biophys Res Commun 2007, 357:1148-1153 (Pubitemid 46693691)
35. Nedjadi T, Kitteringham N, Campbell F, Jenkins RE, Park BK, Navarro P, Ashcroft F, Tepikin A, Neoptolemos JP, Costello E: S100A6 binds to annexin 2 in pancreatic cancer cells and promotes pancreatic cancer cell motility. Br J Cancer 2009, 101:1145-1154
36. Kleinjan DA, van Heyningen V: Long-range control of gene expression: emerging mechanisms and disruption in disease. Am J Hum Genet 2005, 76:8-32 (Pubitemid 40023762)
37. Wicki R, Franz C, Scholl FA, Heizmann CW, Schafer BW: Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site-specific hypermethylation. Cell Calcium 1997, 22:243-254 (Pubitemid 27490305)
38. Rosty C, Ueki T, Argani P, Jansen M, Yeo CJ, Cameron JL, Hruban RH, Goggins M: Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol 2002, 160:45-50
39. Sato N, Fukushima N, Matsubayashi H, Goggins M: Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling. Oncogene 2004, 23:1531-1538 (Pubitemid 38406515)
40. Feng G, Xu X, Youssef EM, Lotan R: Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Cancer Res 2001, 61:7999-8004 (Pubitemid 33049393)
41. Nakamura N, Takenaga K: Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin Exp Metastasis 1998, 16:471-479 (Pubitemid 29098810)
42. Rothenburg S, Koch-Nolte F, Thiele HG, Haag F: DNA methylation contributes to tissue- and allele-specific expression of the T-cell differentiation marker RT6. Immunogenetics 2001, 52:231-241 (Pubitemid 32142810)
43. Guo Y, Engelhardt M, Wider D, Abdelkarim M, Lubbert M: Effects of 5-aza-2′-deoxycytidine on proliferation, differentiation and p15/INK4b regulation of human hematopoietic progenitor cells. Leukemia 2006, 20:115-121
44. Ito T: Role of histone modification in chromatin dynamics. J Biochem 2007, 141:609-614
45. Bender J: Chromatin-based silencing mechanisms. Curr Opin Plant Biol 2004, 7:521-526
46. Sandberg R, Ernberg I: Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI). Proc Natl Acad Sci USA 2005, 102:2052-2057 (Pubitemid 40262010)
47. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT, Pergamenschikov A, Williams CF, Zhu SX, Lee JC, Lashkari D, Shalon D, Brown PO, Botstein D: Distinctive gene expression patterns in human mammary epithelial cells and breast cancers, Proc Natl Acad Sci USA 1999, 96:9212-9217 (Pubitemid 29374734)
48. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van de Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO: Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000, 24:227-235
49. Strahl BD, Allis CD: The language of covalent histone modifications. Nature 2000, 403:41-45
50. Hansen JC, Tse C, Wolffe AP: Structure and function of the core histone N-termini: more than meets the eye. Biochemistry 1998, 37:17637-17641
51. Kuo MH, Brownell JE, Sobel RE, Ranalli TA, Cook RG, Edmondson DG, Roth SY, Allis CD: Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines. Nature 1996, 383:269-272